$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
How much does Asciminib cost?
2026-02-01 22:25:32
Check Details
Asciminib resistance treatment
2026-02-01 22:25:32
Check Details
Where to buy Asciminib
2026-02-01 22:25:32
Check Details
Is Asciminib covered by medical insurance?
2026-02-01 22:25:32
Check Details
Sotorasib combined with panitumumab in the treatment of mutant refractory colorectal cancer KRASG12C
2026-02-01 22:25:32
Check Details
Sotorasib 960 mg vs. 240 mg in pretreated KRAS G12C high-grade non-small cell lung cancer
2026-02-01 22:25:32
Check Details
Sotorasib plus panitumumab extends PFS in refractory KRAS G12C+ mCRC
2026-02-01 22:25:32
Check Details
Tepotinib continues to show positive results in METex14-skipped NSCLC
2026-02-01 22:25:32
Check Details
Tepotinib combined with osimertinib may provide a chemotherapy-free option for patients with non-small cell lung cancer after first-line osimertinib treatment
2026-02-01 22:25:32
Check Details
Tepotinib/osimertinib combination induces ORR benefit in EGFR mutated non-small cell lung cancer
2026-02-01 22:25:32
Check Details
Tepotinib and gefitinib show long OS in MET-amplified EGFR+ non-small cell lung cancer
2026-02-01 22:25:32
Check Details
Tepotinib demonstrates durable benefits of high-level methionine MET amplification
2026-02-01 22:25:32
Check Details
1
2
...
335
336
337
338
339
340
341
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma